Hajime Yoshifuji

Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis

Hideaki Tsuji, Ran Nakashima, Yuji Hosono et al. · Arthritis & Rheumatology · 2019 · 361 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases

Mineto Ota, Yasuo Nagafuchi, Hiroaki Hatano et al. · Cell · 2021 · 347 citations

Life Sciences, Genetics, Immunology +16

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

Ran Nakashima, Yoshitaka Imura, Shio Kobayashi et al. · Lara D. Veeken · 2009 · 330 citations

Life Sciences, Immunology, Pathology +17

Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies

Hajime Yoshifuji, Takao Fujii, Shio Kobayashi et al. · Autoimmunity · 2006 · 207 citations

Life Sciences, Immunology, Internal Medicine +17

Two Susceptibility Loci to Takayasu Arteritis Reveal a Synergistic Role of the IL12B and HLA-B Regions in a Japanese Population

Chikashi Terao, Hajime Yoshifuji, Akinori Kimura et al. · The American Journal of Human Genetics · 2013 · 163 citations · Full text

Life Sciences, Immunology, Molecular Medicine +9